These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20399482)

  • 1. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
    Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
    Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma.
    Machado I; López Guerrero JA; Navarro S; Mayordomo E; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2013 Jun; 462(6):665-71. PubMed ID: 23681112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
    El-Badawi ZH; Muhammad EM; Noaman HH
    Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
    Salas S; de Pinieux G; Gomez-Brouchet A; Larrousserie F; Leroy X; Aubert S; Decouvelaere AV; Giorgi R; Fernandez C; Bouvier C
    Virchows Arch; 2009 Jan; 454(1):81-7. PubMed ID: 19050913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma.
    Wan Y; Zhao W; Jiang Y; Liu D; Meng G; Cai Y
    Hum Pathol; 2014 Jul; 45(7):1459-65. PubMed ID: 24746516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma.
    Hosono A; Yamaguchi U; Makimoto A; Endo M; Watanabe A; Shimoda T; Kaya M; Matsumura T; Sonobe H; Kusumi T; Yamaguchi T; Hasegawa T
    J Clin Pathol; 2007 Apr; 60(4):410-4. PubMed ID: 16822878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
    Jiang L; Liu J; Wei Q; Wang Y
    Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
    Chiba H; Matsuyama T
    Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD138 (syndecan-1) expression in bone-forming tumors.
    Nunez AL; Siegal GP; Reddy VV; Wei S
    Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
    Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma.
    Inoue T; Hagiyama M; Enoki E; Sakurai MA; Tan A; Wakayama T; Iseki S; Murakami Y; Fukuda K; Hamanishi C; Ito A
    Life Sci; 2013 Jan; 92(1):91-9. PubMed ID: 23142238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
    Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
    Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.